Search Within

Yuhong She

Formats
  1. Journal Article (16)
  2. Meeting Abstract (15)
Groups
  1. Department of Medicine (20)
  2. GSK Faculty (15)
  3. Sloan Kettering Institute Faculty (15)
  4. Solid Tumor Oncology Division (14)
  5. Molecular Pharmacology and Chemistry Program Faculty (13)
  6. Genitourinary Oncology Service (12)

More Groups

People
  1. Francis Sirotnak (19)
  2. Howard Scher (8)
  3. David Solit (7)
  4. Neal Rosen (7)
  5. Gary Schwartz (6)
  6. Fei Lee (5)

More People

Years
  1. 2009 (1)
  2. 2007 (1)
  3. 2006 (5)
  4. 2005 (6)
  5. 2004 (3)
  6. 2003 (7)

More Years

Publications
  1. Clinical Cancer Research (9)
  2. Cancer Research (4)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (4)
  4. Annals of Surgical Oncology (1)
  5. Blood (1)
  6. EJC Supplements (1)

More Publications

Publishers
  1. American Association for Cancer Research (18)
  2. Elsevier Science, Inc. (2)
  3. Nature Publishing Group (2)
  4. American Chemical Society (1)
  5. American Society for Clinical Investigation (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Flavopiridol monotherapy has antiproliferative activity in a panel of soft tissue sarcoma cell lines as well as in vivo antitumor efficacy
    Meeting Abstract

    Sambol, E. B.; Kennealey, P. T.; Motwani, M.; She, Y.; Geha, R. C.; O'Connor, R.; Schwartz, G. K.; Singer, S.
    Annals of Surgical Oncology (2005)

    Fulltext@MSK | Save
  • NMR detectable cholesterol is an early marker of tumor response to cytotoxic chemotherapy in colon cancer xenografts
    Meeting Abstract

    Kennealey, P. T.; Sambol, E. B.; Decarolis, P.; Geha, R. C.; She, Y. H.; Schwartz, G. K.; Chen, J. H.; Singer, S.
    Journal of the American College of Surgeons (2005)

    Fulltext@MSK | Save
  • Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sensitizing tumors to paclitaxel
    Journal Article

    Solit, D. B.; She, Y.; Lobo, J.; Kris, M. G.; Scher, H. I.; Rosen, N.; Sirotnak, F. M.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro
    Journal Article

    Lin, H.; She, Y. H.; Cassileth, B. R.; Sirotnak, F.; Rundles, S. C.
    International Immunopharmacology (2004)

    Fulltext@MSK | Save
  • Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics
    Journal Article

    Lee, M. D.; She, Y.; Soskis, M. J.; Borella, C. P.; Gardner, J. R.; Hayes, P. A.; Dy, B. M.; Heaney, M. L.; Philips, M. R.; Bornmann, W. G.; more...
    Journal of Clinical Investigation (2004)

    Fulltext@MSK | Save
  • Microarray analysis of prostate cancer progression to reduced androgen dependence: Studies in unique models contrasts early and late molecular events
    Journal Article

    Sirotnak, F. M.; She, Y.; Khokhar, N. Z.; Hayes, P.; Gerald, W.; Scher, H. I.
    Molecular Carcinogenesis (2004)

    Fulltext@MSK | Save
  • Pulsatile administration of the EGF receptor inhibitor Iressa (ZD1839) is significantly more effective than continuous dosing for sensitizing tumors to taxol
    Meeting Abstract

    Solit, D. B.; She, Y.; Moasser, M. M.; Hudis, C. A.; Kris, M. G.; Scher, H. I.; Rosen, N.; Sirotnak, F. M.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Design, synthesis, and SAR of 2nd generation actinonin analogs
    Meeting Abstract

    Borella, C. P.; Lee, M.; Ju, H.; She, Y.; Sirotnak, F.; Scheinberg, D. A.; Tong, W. P.; Bornmann, W. G.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Pulsatile administration of the EGF receptor inhibitor gefitinib (Iressa, ZD 1839) is significantly more effective than continuous dosing for sensitizing tumors to Taxol
    Meeting Abstract

    Solit, D. B.; She, Y.; Moasser, M.; Hudis, C.; Kris, M.; Scher, H.; Rosen, N.; Sirotnak, F. M.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression
    Journal Article

    Wang, E. S.; O'connor, O.; She, Y.; Zelenetz, A. D.; Sirotnak, F. M.; Moore, M. A. S.
    Leukemia and Lymphoma (2003)

    Fulltext@MSK | Save